Celltrion Gets Ready To Push Tocilizumab Into Phase III

Korean Company Offers Latest Details On Plans For Actemra/RoActemra Biosimilar

 
• By David Wallace
  
Clinical Trial Icon
Celltrion’s CT-P47 candidate is ready to enter Phase III trials • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products